本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ALX Oncology Holdings

0.5303
-0.0114-2.10%
盘后0.53030.00000.00%16:00 EDT
成交量:42.70万
成交额:22.67万
市值:2,830.96万
市盈率:-0.21
高:0.5642
开:0.5200
低:0.5115
收:0.5417
数据加载中...
2024/07/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/17

重要事件披露

Form 8-K - Current report
2024/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

重要事件披露

Form 8-K - Current report
2024/04/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/08

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/08

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/07

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/26

重要事件披露

Form 8-K - Current report
2023/12/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/14

重要事件披露

Form 8-K - Current report